Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: Successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion

被引:8
作者
Keil, F
Kalhs, P
Haas, OA
Fritsch, G
Mitterbauer, G
Brugger, S
Lechner, K
Schwarzinger, I
Mannhalter, C
Linkesch, W
Kurz, M
Greinix, HT
机构
[1] ST ANNA CHILDRENS HOSP,CHILDRENS CANC RES INST,VIENNA,AUSTRIA
[2] UNIV VIENNA,CLIN INST MED & CHEM LAB DIAGNOST,A-1010 VIENNA,AUSTRIA
[3] UNIV VIENNA,DEPT MED 1,DIV HAEMATOL & HAEMOSTASEOL,A-1010 VIENNA,AUSTRIA
[4] UNIV VIENNA,DEPT TRANSFUS MED,A-1010 VIENNA,AUSTRIA
关键词
Ph(+) chronic myeloid leukaemia; donor leucocyte infusion induced aplasia; marrow graft failure;
D O I
10.1046/j.1365-2141.1996.d01-1770.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a patient with chronic myeloid leukaemia who underwent allogeneic marrow transplantation (BMT) but had a molecular relapse 5 months and haematological relapse 15 months after BMT. Since therapy with alpha-interferon had been ineffective bet received leucocyte infusions from his sibling donor, He developed acute graft-versus-host disease and became aplastic 6 weeks later. Despite donor marrow infusion and cytokine stimulation marrow aplasia persisted for 13 weeks. Then, donors' peripheral blood stem cells were given after conditioning with cyclophosphamide and antithymocyte globulin resulting in trilineage engraftment of donor haemopoiesis. Since then, the patient has been in continuous molecular remission for 11 months.
引用
收藏
页码:120 / 122
页数:3
相关论文
共 10 条
  • [1] HEMATOPOIETIC PROGENITOR-CELL FUNCTION AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION - INFLUENCE OF CHRONIC GRAFT-VERSUS-HOST DISEASE
    ATKINSON, K
    NORRIE, S
    CHAN, P
    ZEHNWIRTH, B
    DOWNS, K
    BIGGS, J
    [J]. INTERNATIONAL JOURNAL OF CELL CLONING, 1986, 4 (03): : 203 - 220
  • [2] DETECTION OF CHIMERIC BCR-ABL GENES ON BONE-MARROW SAMPLES AND BLOOD SMEARS IN CHRONIC MYELOID AND ACUTE LYMPHOBLASTIC-LEUKEMIA BY IN-SITU HYBRIDIZATION
    BENTZ, M
    CABOT, G
    MOOS, M
    SPEICHER, MR
    GANSER, A
    LICHTER, P
    DOHNER, H
    [J]. BLOOD, 1994, 83 (07) : 1922 - 1928
  • [3] FRITSCH G, 1993, BLOOD, V81, P2301
  • [4] DETECTION OF ENGRAFTMENT AND MIXED CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION USING PCR AMPLIFICATION OF A HIGHLY VARIABLE REGION-VARIABLE NUMBER OF TANDEM REPEATS (VNTR) IN THE VONWILLEBRAND-FACTOR GENE
    GAIGER, A
    MANNHALTER, C
    HINTERBERGER, W
    HAAS, O
    MAROSI, C
    KIER, P
    EICHINGER, S
    FUNOVIC, M
    LECHNER, K
    [J]. ANNALS OF HEMATOLOGY, 1991, 63 (04) : 227 - 228
  • [5] GOLDMAN JM, 1993, BLOOD, V82, P2235
  • [6] GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS
    KOLB, HJ
    SCHATTENBERG, A
    GOLDMAN, JM
    HERTENSTEIN, B
    JACOBSEN, N
    ARCESE, W
    LJUNGMAN, P
    FERRANT, A
    VERDONCK, L
    NIEDERWIESER, D
    VANRHEE, F
    MITTERMUELLER, J
    DEWITTE, T
    HOLLER, E
    ANSARI, H
    [J]. BLOOD, 1995, 86 (05) : 2041 - 2050
  • [7] MITTERBAUER G, 1995, BRIT J HAEMATOL, V89, P937
  • [8] NAKAO S, 1992, BONE MARROW TRANSPL, V9, P107
  • [9] INDUCTION OF GRAFT-VERSUS-HOST DISEASE AS IMMUNOTHERAPY FOR RELAPSED CHRONIC MYELOID-LEUKEMIA
    PORTER, DL
    ROTH, MS
    MCGARIGLE, C
    FERRARA, JLM
    ANTIN, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (02) : 100 - 106
  • [10] STORB R, 1987, BLOOD, V70, P1116